U.S. Markets open in 80 hrs, 6 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,543.55 | -171.63 | -1.47% |
| NASDAQ | 2,367.52 | -44.12 | -1.83% |
| S&P 500 | 1,282.83 | -17.85 | -1.37% |
| Day Low 12:54 PM EDT | 3.81 | |
|---|---|---|
| Day High 09:44 AM EDT | 3.95 |
|
| Range | 0.14 | |
| Volume | 203,148 | |
| 30-Day Avg. Vol. | 291,000 |
|
| Difference | -30.19% | |
| Market Cap. | 292.51 M | |
| Change | 746,200 | |
| Shares Out. | 74.62 M | |
| Percent Traded | 0.27% | |
| Revenue | — | |
| Earnings | — | |
| EPS (TTM) | -0.83 |
| 52-Wk Low 3/17/08 | 2.42 | |
|---|---|---|
| 52-Wk High 8/29/07 | 6.08 |
|
| Range | 3.66 | |
| Prev. Close 8/28/08 | 3.91 | |
| Today's Open | 3.94 | |
| Change | 0.77% | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | 0.8294 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
QLT's drugs respond to a light touch. The company develops pharmaceuticals that are activated when exposed to light. Visudyne, developed and marketed with Novartis Ophthalmics, fights a type of age-related ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — — | — — |
—
—
|
| Last Quarter | — — | — — |
—
—
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
Real-Time Quote
